Zhuge X. et al. reported that elevated CA 19-9 and CEA levels are typically observed in low-grade neuroendocrine tumors, which can aid in differentiating between epithelial and neuroendocrine pancreatic tumors. This evidence concerns the gene CEACAM5 and neuroendocrine neoplasm.